We are live on ! Find out more
AIM

Acrospire Investment Management Portfolio holdings

AUM $33K
1-Year Est. Return 24.6%
This Fund
S&P 500
This Quarter Est. Return
+5.13%
1 Year Est. Return
+24.6%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$107M
AUM Growth
-$14.5M
Cap. Flow
-$16.8M
Cap. Flow %
-15.73%
Top 10 Hldgs %
2.69%
Holding
2,904
New
705
Increased
558
Reduced
830
Closed
739

Top Buys

Rank Stock Value
1
PG icon
Procter & Gamble
PG
+$423K
2
GIS icon
General Mills
GIS
+$314K
3
MO icon
Altria Group
MO
+$234K
4
PX
Praxair Inc
PX
+$231K
5
ATR icon
AptarGroup
ATR
+$231K

Sector Composition

Rank Sector Weight
1 Industrials 15.12%
2 Healthcare 14.17%
3 Financials 13.11%
4 Consumer Discretionary 12.41%
5 Technology 11.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMWD
476
DELISTED
American Woodmark
AMWD
$73K 0.07%
764
+600
+366% +$55.1K
CDE icon
477
Coeur Mining
CDE
$18.3B
$73K 0.07%
+8,502
New +$77.2K
CENT icon
478
Central Garden & Pet Co
CENT
$2.74B
$73K 0.07%
2,854
-5,752
-67% -$156K
FNWB icon
479
First Northwest Bancorp
FNWB
$105M
$73K 0.07%
+4,643
New +$75.6K
FORR icon
480
Forrester Research
FORR
$221M
$73K 0.07%
1,866
+1,500
+410% +$59.3K
GLW icon
481
Corning
GLW
$140B
$73K 0.07%
2,414
+2,400
+17,143% +$69K
KLAC icon
482
KLA
KLAC
$254B
$73K 0.07%
8,000
+4,000
+100% +$39.9K
MZTI
483
The Marzetti Company
MZTI
$3.15B
$73K 0.07%
+598
New +$74.9K
MIDD icon
484
Middleby
MIDD
$5.92B
$73K 0.07%
600
+500
+500% +$66K
NRC icon
485
NRC Health Common Stock
NRC
$454M
$73K 0.07%
2,698
+732
+37% +$17.9K
NSC icon
486
Norfolk Southern
NSC
$75.4B
$73K 0.07%
600
+200
+50% +$23.5K
PBI icon
487
Pitney Bowes
PBI
$2.36B
$73K 0.07%
4,844
-1,324
-21% -$19.3K
PGC icon
488
Peapack-Gladstone Financial
PGC
$805M
$73K 0.07%
2,336
-3,300
-59% -$101K
PKBK icon
489
Parke Bancorp
PKBK
$404M
$73K 0.07%
3,948
+2,624
+198% +$45.3K
TGT icon
490
Target
TGT
$68.6B
$73K 0.07%
+1,405
New +$76.8K
TSN icon
491
Tyson Foods
TSN
$20.2B
$73K 0.07%
1,158
-4,400
-79% -$270K
BKEP
492
DELISTED
Blueknight Energy Partners L.P.
BKEP
$73K 0.07%
11,699
+5,831
+99% +$39.5K
WCG
493
DELISTED
Wellcare Health Plans, Inc.
WCG
$73K 0.07%
409
NTRI
494
DELISTED
NutriSystem, Inc.
NTRI
$73K 0.07%
1,400
BEN icon
495
Franklin Resources
BEN
$17.2B
$72K 0.07%
1,600
+1,500
+1,500% +$64.1K
DRI icon
496
Darden Restaurants
DRI
$24.6B
$72K 0.07%
800
-500
-38% -$43.7K
EMR icon
497
Emerson Electric
EMR
$88.6B
$72K 0.07%
1,200
+700
+140% +$41.5K
GMED icon
498
Globus Medical
GMED
$11.4B
$72K 0.07%
2,162
+1,200
+125% +$37.7K
ITT icon
499
ITT
ITT
$18.9B
$72K 0.07%
+1,800
New +$71.8K
PHG icon
500
Philips
PHG
$26.4B
$72K 0.07%
2,653
+473
+22% +$12.4K

Similar funds

Acrospire Investment Management's Q2 2017 Portfolio in Review

As of Q2 2017, Acrospire Investment Management held 2,904 positions worth $107M, down 12% from $121M the previous quarter. Its ten largest holdings account for 2.7% of the portfolio.

Acrospire Investment Management withdrew a net $16.8M in Q2 2017, closing 739 positions and reducing 830 holdings. Its most notable exit was Bunge Global, an estimated $285K position sold in full.

By sector, the portfolio is most concentrated in Industrials at 15% of assets, up from 15% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Acrospire Investment Management opened a new position in Procter & Gamble worth $418K.

  • Acrospire Investment Management's largest Q2 2017 buy was Procter & Gamble: 4,800 shares worth $418K.
  • Acrospire Investment Management added most to General Mills in Q2 2017, an estimated $314K increase.
  • Acrospire Investment Management's biggest Q2 2017 reduction was Navios Maritime Acquisition Corporation, cutting an estimated $1.35M.
  • Acrospire Investment Management fully exited Bunge Global in Q2 2017, selling an estimated $285K.
  • Acrospire Investment Management's ten largest holdings make up 2.7% of its $107M portfolio in Q2 2017.
  • Acrospire Investment Management opened 705 new positions and closed 739 in Q2 2017.
  • Acrospire Investment Management's portfolio value fell 12% quarter-over-quarter to $107M.

Based on Acrospire Investment Management's 13F filing for Q2 2017, filed 11 Aug 2017.